Wound Treatments - France
In 2009, sales of wound treatments increased by 1% in current value terms to reach EUR114mn. Wound treatment value sales were boosted by sticking plasters, where innovative products offering greater technical advances and patient comfort registered the best performance.
Euromonitor International's Wound Treatments Products in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:Other Wound Treatments, Sticking Plasters
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Euromonitor International's Wound Treatments Products in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2005-2009, allowing you to identify the sectors driving growth. Forecasts to 2014 illustrate how the market is set to change.
Product coverage:Other Wound Treatments, Sticking Plasters
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Consumer Health industry;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Executive Summary
Consumer Health Lacks Dynamism
Launch of OTC Obesity Causes Controversy in Consumer Health
Consumer Health Characterised by Fragmented Competitive Environment
Chemists/pharmacies Continue To Dominate Retail Channels
Lack of Growth Will Cause Stagnation
Key Trends and Developments
Self-service: Old Habits Die Hard As Consumers Prefer Advice From Chemists/pharmacists
Consumer Health Battles Against 'alicaments', Highly Functional Foods
Stressful, Busy Lifestyles Influence Natural Choices
Fat Fighting - OTC Obesity Category Launched With New Product Alli
Consumer Health Is Fragmented But Targeted
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication/self-care and Preventive Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Arkopharma Sa, Laboratoires Pharmaceutiques
Strategic Direction
Key Facts
Summary 3 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts
Summary 4 Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators
Company Background
Competitive Positioning
Summary 5 Laboratoires Pharmaceutiques Arkopharma SA: Competitive Position 2009
Beaufour-ipsen SA
Strategic Direction
Key Facts
Summary 6 Beaufour-Ipsen SA: Key Facts
Summary 7 Beaufour-Ipsen SA: Operational Indicators
Company Background
Production
Summary 8 Beaufour-Ipsen SA: Production Statistics
Competitive Positioning
Summary 9 Beaufour-Ipsen SA: Competitive Position 2009
Cooper SA
Strategic Direction
Key Facts
Summary 10 Cooper SA: Key Facts
Summary 11 Cooper SA: Operational Indicators
Company Background
Production
Summary 12 Cooper SA: Production Statistics
Competitive Positioning
Summary 13 Cooper SA: Competitive Position 2009
GlaxoSmithKline Santé Grand Public Sas
Strategic Direction
Key Facts
Summary 14 GlaxoSmithKline Santé Grand Public SAS: Key Facts
Summary 15 GlaxoSmithKline Santé Grand Public SAS: Operational Indicators
Company Background
Production
Summary 16 GlaxoSmithKline France: Production Statistics
Competitive Positioning
Summary 17 GlaxoSmithKline Santé Grand Public SAS: Competitive Position 2009
Juva Santé, Groupe
Strategic Direction
Key Facts
Summary 18 Laboratoires Juva Santé: Key Facts
Company Background
Production
Summary 20 Laboratoires Juva Santé: Production Statistics
Competitive Positioning
Summary 21 Laboratoires Juva Santé: Competitive Position 2009
Laboratoires Mcneil
Strategic Direction
Key Facts
Summary 22 Laboratoires McNeil: Key Facts
Summary 23 Laboratoires McNeil: Operational Indicators
Company Background
Competitive Positioning
Summary 24 Laboratoires McNeil: Competitive Position 2009
Pierre Fabre Sa, Laboratoires
Strategic Direction
Key Facts
Summary 25 Laboratoires Pierre Fabre SA: Key Facts
Summary 26 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
Summary 27 Laboratoires Pierre Fabre SA: Production Statistics
Competitive Positioning
Summary 28 Laboratoires Pierre Fabre SA: Competitive Position 2009
Théraplix SA
Strategic Direction
Key Facts
Summary 29 Théraplix SA: Key Facts
Company Background
Competitive Positioning
Summary 30 Théraplix SA: Competitive Position 2009
Upsa, Laboratoires
Strategic Direction
Key Facts
Summary 31 Laboratoires UPSA: Key Facts
Summary 32 Laboratoires UPSA: Operational Indicators
Company Background
Production
Summary 33 Laboratoires UPSA: Production Statistics
Competitive Positioning
Summary 34 Laboratoires UPSA: Competitive Position 2009
Urgo, Laboratoires
Strategic Direction
Key Facts
Summary 35 Laboratoires Urgo: Key Facts
Summary 36 Laboratoires Urgo: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 37 Laboratoires Urgo: Competitive Position 2009
Trends
Category Data
Table 12 Sales of Wound Treatments by Subsector: Value 2004-2009
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Table 14 Wound Treatments Company Shares by Value 2005-2009
Table 15 Wound Treatments Brand Shares by Value 2006-2009
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014
Consumer Health Lacks Dynamism
Launch of OTC Obesity Causes Controversy in Consumer Health
Consumer Health Characterised by Fragmented Competitive Environment
Chemists/pharmacies Continue To Dominate Retail Channels
Lack of Growth Will Cause Stagnation
Key Trends and Developments
Self-service: Old Habits Die Hard As Consumers Prefer Advice From Chemists/pharmacists
Consumer Health Battles Against 'alicaments', Highly Functional Foods
Stressful, Busy Lifestyles Influence Natural Choices
Fat Fighting - OTC Obesity Category Launched With New Product Alli
Consumer Health Is Fragmented But Targeted
Market Indicators
Table 1 Consumer Expenditure on Health Goods and Medical Services 2004-2009
Table 2 Life Expectancy at Birth 2004-2009
Market Data
Table 3 Sales of Consumer Health by Sector: Value 2004-2009
Table 4 Sales of Consumer Health by Sector: % Value Growth 2004-2009
Table 5 Consumer Health Company Shares by Value 2005-2009
Table 6 Consumer Health Brand Shares by Value 2006-2009
Table 7 Penetration of Private Label by Sector 2004-2009
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2004-2009
Table 9 Sales of Consumer Health by Sector and Distribution Format: % Analysis 2009
Table 10 Forecast Sales of Consumer Health by Sector: Value 2009-2014
Table 11 Forecast Sales of Consumer Health by Sector: % Value Growth 2009-2014
Appendix
OTC Registration and Classification
Advertising
Packaging and Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication/self-care and Preventive Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2007-2009
Definitions
Sector and Subsector Definitions
Summary 2 Research Sources
Arkopharma Sa, Laboratoires Pharmaceutiques
Strategic Direction
Key Facts
Summary 3 Laboratoires Pharmaceutiques Arkopharma SA: Key Facts
Summary 4 Laboratoires Pharmaceutiques Arkopharma SA: Operational Indicators
Company Background
Competitive Positioning
Summary 5 Laboratoires Pharmaceutiques Arkopharma SA: Competitive Position 2009
Beaufour-ipsen SA
Strategic Direction
Key Facts
Summary 6 Beaufour-Ipsen SA: Key Facts
Summary 7 Beaufour-Ipsen SA: Operational Indicators
Company Background
Production
Summary 8 Beaufour-Ipsen SA: Production Statistics
Competitive Positioning
Summary 9 Beaufour-Ipsen SA: Competitive Position 2009
Cooper SA
Strategic Direction
Key Facts
Summary 10 Cooper SA: Key Facts
Summary 11 Cooper SA: Operational Indicators
Company Background
Production
Summary 12 Cooper SA: Production Statistics
Competitive Positioning
Summary 13 Cooper SA: Competitive Position 2009
GlaxoSmithKline Santé Grand Public Sas
Strategic Direction
Key Facts
Summary 14 GlaxoSmithKline Santé Grand Public SAS: Key Facts
Summary 15 GlaxoSmithKline Santé Grand Public SAS: Operational Indicators
Company Background
Production
Summary 16 GlaxoSmithKline France: Production Statistics
Competitive Positioning
Summary 17 GlaxoSmithKline Santé Grand Public SAS: Competitive Position 2009
Juva Santé, Groupe
Strategic Direction
Key Facts
Summary 18 Laboratoires Juva Santé: Key Facts
Company Background
Production
Summary 20 Laboratoires Juva Santé: Production Statistics
Competitive Positioning
Summary 21 Laboratoires Juva Santé: Competitive Position 2009
Laboratoires Mcneil
Strategic Direction
Key Facts
Summary 22 Laboratoires McNeil: Key Facts
Summary 23 Laboratoires McNeil: Operational Indicators
Company Background
Competitive Positioning
Summary 24 Laboratoires McNeil: Competitive Position 2009
Pierre Fabre Sa, Laboratoires
Strategic Direction
Key Facts
Summary 25 Laboratoires Pierre Fabre SA: Key Facts
Summary 26 Laboratoires Pierre Fabre SA: Operational Indicators
Company Background
Production
Summary 27 Laboratoires Pierre Fabre SA: Production Statistics
Competitive Positioning
Summary 28 Laboratoires Pierre Fabre SA: Competitive Position 2009
Théraplix SA
Strategic Direction
Key Facts
Summary 29 Théraplix SA: Key Facts
Company Background
Competitive Positioning
Summary 30 Théraplix SA: Competitive Position 2009
Upsa, Laboratoires
Strategic Direction
Key Facts
Summary 31 Laboratoires UPSA: Key Facts
Summary 32 Laboratoires UPSA: Operational Indicators
Company Background
Production
Summary 33 Laboratoires UPSA: Production Statistics
Competitive Positioning
Summary 34 Laboratoires UPSA: Competitive Position 2009
Urgo, Laboratoires
Strategic Direction
Key Facts
Summary 35 Laboratoires Urgo: Key Facts
Summary 36 Laboratoires Urgo: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 37 Laboratoires Urgo: Competitive Position 2009
Trends
Category Data
Table 12 Sales of Wound Treatments by Subsector: Value 2004-2009
Table 13 Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Table 14 Wound Treatments Company Shares by Value 2005-2009
Table 15 Wound Treatments Brand Shares by Value 2006-2009
Table 16 Forecast Sales of Wound Treatments by Subsector: Value 2009-2014
Table 17 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2009-2014